Personal Care Ice Gel Recalled Due to Insanitary Conditions and Rodent Exposure
Gold Star Distribution Inc is recalling Personal Care Ice Gel (8oz, 12 count) distributed nationwide due to insanitary conditions and rodent exposure in its distribution center.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall for CGMP violations. The identified rodent exposure and insanitary conditions in the distribution center represent a risk-of-harm situation, though no illnesses or injuries have been reported.
Plain-English summary
Gold Star Distribution Inc is recalling Personal Care Ice Gel (8oz, 12 count, UPC 048155903463) that was distributed nationwide. The recall is due to current good manufacturing practice (CGMP) deviations identified in the company's distribution center.
The company discovered insanitary conditions including rodent exposure and activity in its distribution center. This creates a potential risk of contamination for products handled in that facility.
All lots of the product that were within expiration date and distributed by Gold Star Distribution are included in this recall. Consumers who have purchased this product should stop using it and may contact the manufacturer for further information.
The recalled product
- Product
- Personal Care, Ice Gel, 8oz, 12 count, UPC 048155903463
- Manufacturer
- GOLD STAR DISTRIBUTION INC
- Category
- Drug — Personal Care
- Hazard
- rodent-exposure
- insanitary-conditions
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots within expiry distributed by Gold Star Distribution.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27